Saturday, Jul 21 2018 | Time 07:45 Hrs(IST)
  • Hiding in Nicaragua, Ortega's battered opponents plan comeback
  • Concern in White House over intelligence chief's Russian summit surprise
  • Canada's immigration detention reviews stacked against detainees -audit
  • Incoming Mexico leader blasts campaign fine as 'act of vengeance'
  • Amazon, Toyota, Alcoa and others working to counter Trump's tariff plans
  • Missouri tourist boat tragedy claims lives of 9 family members, others
  • Israel, Hamas agree to restore calm in Gaza Strip -Hamas
  • After win against 'No Trust' motion, PM says Govt's efforts to transform India to continue
  • Trump on Putin meeting: it wasn't all rosy
  • Ivory Coast government faces collapse in coalition row
  • US, European allies map out larger role for F-35 fighter
Science Technology Share

WHO advises Dengvaxia be used only in people previously infected with dengue

WHO advises Dengvaxia be used only in people previously infected with dengue

Kolkata, Dec 14 (UNI) Following a consultation of the Global Advisory Committee on Vaccine

Safety, the World Health Organization (WHO) finds that the dengue vaccine CYD-TDV, sold

under the brand name Dengvaxia, prevents disease in the majority of vaccine recipients but

it should not be administered to people who have not previously been infected with dengue


This recommendation is based on new evidence communicated by the vaccine’s

manufacturer (Sanofi Pasteur), indicating an increase in incidence of hospitalization and

severe illness in vaccinated children never infected with dengue.

The WHO Global Advisory Committee on Vaccine Safety considered the company’s new

results from clinical trial data analyses. Those studies indicate that increased risk of severe

dengue disease in people who have never been infected affects about 15 per cent of the

vaccinated individuals.

The magnitude of risk is in the order of about 4 out of every 1000 seronegative patients

vaccinated who developed severe dengue disease during five years of observation. The risk

of developing severe dengue disease in non-vaccinated individuals has been calculated as

1.7 per 1000 over the same period of observation.

By contrast, for the 85 per cent who have had dengue disease before immunization, there

is a reduction of 4 cases of severe dengue per 1 000 who are vaccinated.

The possibility of risk for seronegative people was raised by WHO and published in a

position paper in July 2016: “…vaccination may be ineffective or may theoretically even increase

the future risk of hospitalized or severe dengue illness in those who are seronegative at the time

of first vaccination regardless of age."

As this risk had at that time not been seen in the age groups for which the vaccine was

licensed, WHO issued a conditional recommendation, emphasizing the use of the vaccine

in populations having been previously infected with dengue virus.

To minimize illness for seronegative vaccinated people, WHO recommends enhancing

measures that reduce exposure to dengue infection among populations where the vaccine

has already been administered.

For vaccine recipients who present with clinical symptoms compatible with dengue virus

infection, access to medical care should be expedited to allow for proper evaluation,

identification, and management of severe forms of the disease.

Dengue is a mosquito-borne flavivirus disease that has spread to most tropical and many subtropical areas. The disease is caused by four closely related viruses. There is no specific

dengue treatment and prevention is mainly limited to vector control measures. A safe and

effective dengue vaccine would therefore represent a major advance in the control of the


CYD-TDV is a live attenuated tetravalent vaccine made using recombinant DNA technology

and is administered in three phases separated by six-month intervals. It became commercially available in 2016 and is currently licensed in 19 countries.


More News
Diphtheria an infectious disease caused by bacterium Corynebacterium diphtheria

Diphtheria an infectious disease caused by bacterium Corynebacterium diphtheria

17 Jul 2018 | 8:06 PM

Kolkata, Jul 17 (UNI) Diphtheria is an infectious disease caused by the bacterium Corynebacterium diphtheria, which primarily infects the throat and upper airways and produces a toxin affecting other organs.

 Sharesee more..
Oral health-essential to general health and quality of life

Oral health-essential to general health and quality of life

16 Jul 2018 | 12:05 PM

Kolkata, Jul 16 (UNI) Oral health is essential to general health and quality of life.

 Sharesee more..
Aadhaar in Ayushman Bharat 'not must', clarifies Govt

Aadhaar in Ayushman Bharat 'not must', clarifies Govt

12 Jul 2018 | 3:50 PM

New Delhi, July 12 (UNI) Dismissing media reports that Aadhaar Card would be “must” to avail benefits under the Ayushman Bharat, the Centre on Thursday clarified that Aadhaar was 'desirable' and 'not must'.

 Sharesee more..
Leeches blood-clotting ability can help develop cures: Study

Leeches blood-clotting ability can help develop cures: Study

12 Jul 2018 | 11:29 AM

New Delhi, July 12 (UNI) Blood-feeding leeches have a suite of anticoagulant compounds they secrete from their salivary glands that prevent clotting.

 Sharesee more..

Global platform passes major milstone with publication of one-billionth species record

10 Jul 2018 | 10:08 AM

Hyderabad, Jul 10 (UNI) A global platform for sharing information about the world’s biodiversity has passed a major milestone, with the publication of the one-billionth species record of where a species lives through the Global Biodiversity Information Facility (GBIF).

 Sharesee more..